During the projection period, the market for immune checkpoint inhibitors Market was expected to develop at a CAGR of 18%. A steep rise in the global occurrence of various types of malignancies, along with a sharp increase in the elderly population across geographical areas, mostly in established and emerging nations, is the fundamental driver driving market expansion. According to a World Health Organization report, cancer is the biggest cause of death worldwide, accounting for an anticipated 9.6 million fatalities in 2018, with lung cancer being the most common cause of death, accounting for 1.76 million deaths. As a result, there has been an increase in the number of patients in the pool, as well as improved public awareness and early cancer detection utilizing technologically advanced methods.
Read More @ https://cmiinfopiece.blogspot.com/2022/01/immune-checkpoint-inhibitors-market-is.html
